Protein aggregation plays significant role in cancer development
March 30th, 2011 - 4:19 pm ICT by ANIWashington, Mar 30 (ANI): A new study has found that protein aggregation, which is generally associated with Alzheimer’s and mad cow disease, plays a significant role in cancer development.
Frederic Rousseau and Joost Schymkowitz of VIB, K.U.Leuven and Vrije Universiteit Brussel describe that certain mutations of p53, an important tumour suppressor, cause the protein to misfold in a way that the proteins start to aggregate.
This not only disrupts the protective function of normal p53, but of other related proteins as well.
In the study, the focus was on the p53 protein, which plays a key role in protecting the body against cancer. If p53 works normally, it controls cell division.
If p53 control ceases - e.g. when there is a mutation in the protein - the cells start to divide in an uncontrolled manner and this may result in a tumour.
Mutations in p53 are observed in about half of cancer cases, making the protein an important target in the development of new cancer therapies.
“We have revealed a new mechanism for the action of mutant p53,” Joost Schymkowitz and Frederic Rousseau of VIB, Vrije Universiteit Brussel and K.U. Leuven said.
“Mutations in p53 cause the protein to lose its protective function. The proteins change in shape, hook into each other and begin to aggregate.
“The active p53 disappears from the cell and can no longer carry out its control function properly,” they stated.
The mechanism has been encountered in about one third of p53 mutations.
Moreover, the mutations cause p53 to assume a completely different character. From being a protective factor, the mutated p53 changes into a substance, which in fact speeds up tumour growth.
It seems to form aggregates with control substances (p63 and p73) in the cell, causing them to lose their function as well.
Even though the underlying principle, protein aggregation, occurs similarly in particular cancers, Alzheimer and systemic amyloidosis, the diseases are otherwise totally unconnected with each other.
In cancer, the clustering of p53 protein leads to uncontrolled cell growth. In Alzheimer, clustering of the beta-amyloid protein causes brain cells to die off.
The paper has been published in Nature Chemical Biology. (ANI)
- Restoring gene may slow spread of advanced lung tumours - Nov 25, 2010
- New way to kill cancer cells discovered - Sep 18, 2011
- Scientists complete whole-exome sequencing of skin cancer - Apr 16, 2011
- How loss of key protein promotes aggressive form of leukaemia - Jul 02, 2010
- Cell suicide can trigger cancer growth - Aug 02, 2010
- Study sheds light on behaviour of enzyme linked to Alzheimer's, cancer - Nov 20, 2010
- New research brings cancer vaccine a step closer - Nov 05, 2010
- Genetic mutation linked to premature birth identified - Feb 02, 2010
- New drug shrinks cancer, with few side effects - Apr 07, 2011
- Scientists isolate gene common to unrelated cancers - Jan 02, 2012
- Hormone therapies 'up breast cancer metastasis risk in post-menopausal women' - May 07, 2010
- Even a minor cut 'can trigger tumour' - Feb 15, 2011
- How a vegetarian diet can prevent cancer - Oct 28, 2010
- How broccoli fights cancer - Jan 27, 2011
- 'Low oxygen levels drive cancer growth' - May 06, 2012
Tags: aggregates, amyloidosis, cancer cases, cancer development, cancer therapies, joost, key role, leuven, mad cow disease, mutant p53, p53 mutations, p53 protein, p63, p73, protein aggregation, rousseau, target, uncontrolled manner, vib, vrije universiteit brussel